Latigo Biotherapeutics (LTGO) vs Seaport Therapeutics (SPTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Latigo Biotherapeutics is the larger company by market cap ($980.6 million vs $958.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LTGO | SPTX |
|---|---|---|
| Share price | $14.79 | $17.91 |
| Market cap | $980.57M | $958.73M |
| 1-day change | -4.70% | -0.11% |
| EPS (TTM) | $-2.52 | $-5.81 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $25.93 | $28.38 |
| 52-week low | $14.60 | $14.85 |
| Distance from 52-week high | -42.96% | -36.89% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +253.28% | +113.79% |
| Average volume | 394.20K | 182.18K |
| Shares outstanding | 66.30M | 53.53M |
| Employees | 66 | 58 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Latigo Biotherapeutics
LTGO stock →Latigo Biotherapeutics, Inc. develops non-opioid pain medicines designed to stop the transmission of pain without the risk of addiction.
Health Care · Biotechnology: Pharmaceutical Preparations · 66 employees
About Seaport Therapeutics
SPTX stock →Seaport Therapeutics, Inc., a clinical-stage therapeutics company, focuses on inventing and developing new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. It is leveraging its proprietary Glyph platform to advance a pipeline of therapies to address the unmet needs in depression and anxiety.
Health Care · Biotechnology: Pharmaceutical Preparations · 58 employees
LTGO vs SPTX FAQ
Which is bigger, Latigo Biotherapeutics or Seaport Therapeutics?
Latigo Biotherapeutics (LTGO) is larger, with a market capitalization of $980.57M compared with $958.73M for Seaport Therapeutics (SPTX).
Are Latigo Biotherapeutics and Seaport Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.